Boundless Bio to Present at the Stifel 2023 Virtual Targeted Oncology Days
Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in oncogene amplified cancers, today announced that its President and Chief Executive Officer, Zachary Hornby, will present at the Stifel 2023 Virtual Targeted Oncology Days event which will take place virtually. Presentation details are as follows:
Date: Tuesday, April 25, 2023
Time: 3:30 ? 3:55 PM ET
About Boundless Bio
Boundless Bio is a next-generation precision oncology company dedicated to the discovery and development of new drugs targeting a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with oncogene amplified cancers.
Tranter has secured an order for a cutting-edge direct reduced iron (DRI), green steel plant set to be constructed in Germany. The DRI plant reduces its carbon footprint significantly by using green hydrogen and carbon capture, helping to achieve...
Bybit, one of the world's top three crypto exchanges by volume, is thrilled to announce its collaboration with Airalo, a renowned international eSIM provider. Together, we are poised to revolutionize connectivity and convenience for Bybit Card users...
Proprietary E3 ligase platform to enable protein stabilisation "at source", thereby restoring the body's sophisticated natural disease suppression processes Platform scales the assessment of E3 ligase targets while addressing the historic challenges...
Since its establishment in 2013, Huepar has specialized in the field of measurement tools for 11 years. With unwavering innovation and exceptional product quality, Huepar's products have been sold to over 130 countries worldwide, with more than 20...
Today OLX Group ("OLX"), a global marketplace leader that builds platforms to facilitate trade, announces the appointment of Christian Gisy as CEO.
Christian will be responsible for leading the strategy, growth and development of the company's...
